Market Place
Sourcing Support
IceCure Completes Cryoablation Study; Final Analysis in Q2 2026
23 Feb 2026 //
PR NEWSWIRE
Icecure Installs Prosense At Thomas Hospital, First In Alabama
19 Feb 2026 //
PR NEWSWIRE
IceCure`s ProSense in 4 Breast Cancer Studies at RSNA 2025
10 Dec 2025 //
PR NEWSWIRE
Icecure Granted Chinese Patent For Innovative Cryogen Flow
05 Dec 2025 //
PR NEWSWIRE
IceCure Appoints Shay Levav as COO to Drive Growth
10 Nov 2025 //
PR NEWSWIRE
Icecure Highlights Prosense® At TME Fall Summit Roundtable
13 Oct 2025 //
PR NEWSWIRE
IceCure Granted US Patent Notice for Next-Gen XSense Cryoprobes
18 Sep 2025 //
PR NEWSWIRE
IceCure Gets Israeli Approval for XSense™ Cryoablation System
15 Sep 2025 //
PR NEWSWIRE
IceCure`s ProSense® in THERMAC Trial: 95% Patient Satisfaction
08 Sep 2025 //
PR NEWSWIRE
IceCure`s ProSense Significantly Cut Abdominal Endometriosis Pain
04 Sep 2025 //
PR NEWSWIRE
Ice Cure Gets US Patent for Novel Cryogen Flow Control
09 Jun 2025 //
PR NEWSWIRE
IceCure`s ProSense Featured at SIO 2025 as FDA Decision Approaches
04 Feb 2025 //
PR NEWSWIRE
IceCure CEO Reports 42% Rise In ProSense® Sales In North America
13 Jan 2025 //
PR NEWSWIRE
IceCure’s ProSense® Cryoablation Effective in Kidney Tumor Treatment
05 Dec 2024 //
PR NEWSWIRE
Fda Panel For IceCure`s ProSense® Gets Many Public Comments
29 Oct 2024 //
PR NEWSWIRE
IceCure`s ICE3 5-Year Results Show 96.3% Recurrence-Free for Breast Cancer
24 Sep 2024 //
PR NEWSWIRE
IceCure`s ProSense Shows 97.7% Success Rate In Tumor Treatment
16 Sep 2024 //
PR NEWSWIRE
European Study Supports IceCure`s ProSense For Breast Cancer Treatment
09 Jul 2024 //
PR NEWSWIRE
FDA Clears IceCure`s XSense Cryoablation System With CryoProbes
01 Jul 2024 //
PR NEWSWIRE
IceCure To Report Q1 2024 Results On May 28
21 May 2024 //
PR NEWSWIRE
IceCure Medical Reports Topline Results From ICE3 Cryoablation Breast Cancer
19 Mar 2024 //
PR NEWSWIRE
IceCure Receives Notice of Allowance in Japan for a Novel Cryogen Flow Control
12 Mar 2024 //
PR NEWSWIRE
Scientific Paper by Doctors Using IceCure`s ProSense® Published in Journal
25 Oct 2023 //
PR NEWSWIRE
Health Canada Approves IceCure`s Minimally Invasive ProSense Cryoablation System
24 Jul 2023 //
PR NEWSWIRE
IceCure to Review Recent Progress at Maxim Group`s Healthcare Conference
13 Jun 2023 //
PR NEWSWIRE
IceCure to Report 1Q 2023 FYR & Operational Results on May 22, 2023
15 May 2023 //
PR NEWSWIRE
IceCure Receives Approval in China for IceSense3 Disposable Cryoprobes
28 Mar 2023 //
PR NEWSWIRE
IceCure Medical Announces Preliminary Unaudited 2022 Year-End Financial Results
09 Feb 2023 //
PR NEWSWIRE
IceCure Medical to Report Financial Results for the 9-Month Period Ended Sep
29 Nov 2022 //
PRNEWSWIRE
IceCure`s ProSense Cryoprobes and Introducers Receive Regulatory Approval
11 Oct 2022 //
PRNEWSWIRE
